414 related articles for article (PubMed ID: 17704242)
1. Role of 99mTc-octreotide acetate scintigraphy in suspected lung cancer compared with 18F-FDG dual-head coincidence imaging.
Wang F; Wang Z; Yao W; Xie H; Xu J; Tian L
J Nucl Med; 2007 Sep; 48(9):1442-8. PubMed ID: 17704242
[TBL] [Abstract][Full Text] [Related]
2. The role of technetium-99m-labeled octreotide acetate scintigraphy in suspected breast cancer and correlates with expression of SSTR.
Wang F; Wang Z; Wu J; Qu W; Yao W; Zhao J; Liu Z
Nucl Med Biol; 2008 Aug; 35(6):665-71. PubMed ID: 18678351
[TBL] [Abstract][Full Text] [Related]
3. [Application of technetium-99m labelled sandostatin Somatostatin receptor imaging in the detection of lung cancer].
Wang F; Wang ZZ; Yao WX; Chen ZG; Xie H; Xu CY; Meng QL; Cao Y
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Apr; 28(4):218-20. PubMed ID: 15854427
[TBL] [Abstract][Full Text] [Related]
4. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
[TBL] [Abstract][Full Text] [Related]
6. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
7. [18F-FDG imaging by coincidence circuit SPECT with low-dose CT in preoperative assessment of pulmonary lesions].
Wang Q; Huang LL; Yue MG; Qin SL; Wang Y; Nie YX; Zhang CQ; Liang TJ; Zhao YM
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):924-7. PubMed ID: 17533745
[TBL] [Abstract][Full Text] [Related]
8. Integrin Imaging with
Jin X; Liang N; Wang M; Meng Y; Jia B; Shi X; Li S; Luo J; Luo Y; Cui Q; Zheng K; Liu Z; Shi J; Li F; Wang F; Zhu Z
Radiology; 2016 Dec; 281(3):958-966. PubMed ID: 27479638
[TBL] [Abstract][Full Text] [Related]
9. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
10. An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.
Gabriel M; Decristoforo C; Donnemiller E; Ulmer H; Watfah Rychlinski C; Mather SJ; Moncayo R
J Nucl Med; 2003 May; 44(5):708-16. PubMed ID: 12732671
[TBL] [Abstract][Full Text] [Related]
11. Use of a dual-head coincidence camera and 18F-FDG for detection and nodal staging of non-small cell lung cancer: accuracy as determined by 2 independent observers.
Stevens H; Bakker PF; Schlösser NJ; van Rijk PP; de Klerk JM
J Nucl Med; 2003 Mar; 44(3):336-40. PubMed ID: 12620997
[TBL] [Abstract][Full Text] [Related]
12. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging.
Gallowitsch HJ; Kresnik E; Gasser J; Kumnig G; Igerc I; Mikosch P; Lind P
Invest Radiol; 2003 May; 38(5):250-6. PubMed ID: 12750613
[TBL] [Abstract][Full Text] [Related]
13. In-111 DTPA-octreotide scintigraphy for disease detection in metastatic thyroid cancer: comparison with F-18 FDG positron emission tomography and extensive conventional radiographic imaging.
Sarlis NJ; Gourgiotis L; Guthrie LC; Galen B; Skarulis MC; Shawker TH; Patronas NJ; Reynolds JC
Clin Nucl Med; 2003 Mar; 28(3):208-17. PubMed ID: 12592128
[TBL] [Abstract][Full Text] [Related]
14. Noninferiority of
Dai D; Rollo FD; Bryant J; Kim EE
Contrast Media Mol Imaging; 2018; 2018():8969714. PubMed ID: 29736155
[No Abstract] [Full Text] [Related]
15. Clinical value of technetium-99m-labeled octreotide scintigraphy in local recurrent or metastatic medullary thyroid cancers: a comparison of lesions with 18F-FDG-PET and MIBI images.
Sager S; Kabasakal L; Ocak M; Maecke H; Uslu L; Halaç M; Asa S; Sager G; Önsel Ç; Kanmaz B
Nucl Med Commun; 2013 Dec; 34(12):1190-5. PubMed ID: 24121313
[TBL] [Abstract][Full Text] [Related]
16. Mediastinal lymph node involvement in non-small cell lung cancer: evaluation with 99mTc-tetrofosmin SPECT and comparison with CT.
Schillaci O; Spanu A; Scopinaro F; Monteleone F; Solinas ME; Volpino P; Pirina P; Marongiu P; Cangemi V; Madeddu G
J Nucl Med; 2003 Aug; 44(8):1219-24. PubMed ID: 12902410
[TBL] [Abstract][Full Text] [Related]
17. Comparison of diagnostic ability between (99m)Tc-MDP bone scan and (18)F-FDG PET/CT for bone metastasis in patients with small cell lung cancer.
Lee JW; Lee SM; Lee HS; Kim YH; Bae WK
Ann Nucl Med; 2012 Oct; 26(8):627-33. PubMed ID: 22729551
[TBL] [Abstract][Full Text] [Related]
18. Comparison of [
Chen Z; Fu F; Li F; Zhu Z; Yang Y; Chen X; Jia B; Zheng S; Huang C; Miao W
Mol Imaging Biol; 2018 Oct; 20(5):846-856. PubMed ID: 29497956
[TBL] [Abstract][Full Text] [Related]
19. The usefulness of combined diagnostic CT and (99m)Tc-octreotide somatostatin receptor SPECT/CT imaging on pulmonary nodule characterization in patients.
Wang L; Yin X; Wang F; Gu J; Lu L; Wu Q; Shen B; Li XF
Cancer Biother Radiopharm; 2013 Dec; 28(10):731-6. PubMed ID: 24094076
[TBL] [Abstract][Full Text] [Related]
20. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.
Ho CL; Chen S; Yeung DW; Cheng TK
J Nucl Med; 2007 Jun; 48(6):902-9. PubMed ID: 17504862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
